These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 22734711

  • 1. Pharmacophore Modeling, virtual and in vitro screening for acetylcholinesterase inhibitors and their effects on amyloid-β self- assembly.
    Bag S, Tulsan R, Sood A, Datta S, Török M.
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):2-14. PubMed ID: 22734711
    [Abstract] [Full Text] [Related]

  • 2. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P, Kar S, Roy K.
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [Abstract] [Full Text] [Related]

  • 3. Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease.
    de Almeida JR, Figueiro M, Almeida WP, de Paula da Silva CHT.
    Future Med Chem; 2018 May 01; 10(9):1037-1053. PubMed ID: 29676170
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation.
    Yan JW, Li YP, Ye WJ, Chen SB, Hou JQ, Tan JH, Ou TM, Li D, Gu LQ, Huang ZS.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2527-34. PubMed ID: 22444876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques.
    Gupta S, Fallarero A, Järvinen P, Karlsson D, Johnson MS, Vuorela PM, Mohan CG.
    Bioorg Med Chem Lett; 2011 Feb 15; 21(4):1105-12. PubMed ID: 21273074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY, Itai A.
    J Med Chem; 2004 Sep 23; 47(20):4818-28. PubMed ID: 15369385
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS, Wang XB, Hu XJ, Kong LY.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2636-41. PubMed ID: 23511019
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
    Catto M, Berezin AA, Lo Re D, Loizou G, Demetriades M, De Stradis A, Campagna F, Koutentis PA, Carotti A.
    Eur J Med Chem; 2012 Dec 01; 58():84-97. PubMed ID: 23108363
    [Abstract] [Full Text] [Related]

  • 14. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
    Tang H, Zhao LZ, Zhao HT, Huang SL, Zhong SM, Qin JK, Chen ZF, Huang ZS, Liang H.
    Eur J Med Chem; 2011 Oct 01; 46(10):4970-9. PubMed ID: 21871694
    [Abstract] [Full Text] [Related]

  • 15. Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening.
    Liu G, Jiao Y, Lin Y, Hao H, Dou Y, Yang J, Jiang CS, Chang P.
    Chem Pharm Bull (Tokyo); 2020 Feb 01; 68(2):161-166. PubMed ID: 31813907
    [Abstract] [Full Text] [Related]

  • 16. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M, Park C, Rampogu S, Zeb A, Lee KW.
    Int J Mol Sci; 2019 Feb 25; 20(4):. PubMed ID: 30823604
    [Abstract] [Full Text] [Related]

  • 17. Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay.
    Jang C, Yadav DK, Subedi L, Venkatesan R, Venkanna A, Afzal S, Lee E, Yoo J, Ji E, Kim SY, Kim MH.
    Sci Rep; 2018 Oct 08; 8(1):14921. PubMed ID: 30297729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors.
    Schuster D, Spetea M, Music M, Rief S, Fink M, Kirchmair J, Schütz J, Wolber G, Langer T, Stuppner H, Schmidhammer H, Rollinger JM.
    Bioorg Med Chem; 2010 Jul 15; 18(14):5071-80. PubMed ID: 20580236
    [Abstract] [Full Text] [Related]

  • 20. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
    Zhu Y, Tong XY, Zhao Y, Chen H, Jiang FC.
    Yao Xue Xue Bao; 2008 Mar 15; 43(3):267-76. PubMed ID: 18630262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.